IDH1-R132H enhances oncolytic HSV-1 therapy by facilitating viral entry and immune activation in glioma. - Panagioti E; Kelley HJ; Ling AL; Sejour L; Saini S; Goins WF; Roberts D; Sotiriou S; Bryan Iorgulescu J; Dixon KO; Yaffe MB; Vlachos IS; et al. (Nature communications, 2026)